SPRY1 and central nervous system cancer: Interestingly, SPRY1 mRNA expression was correlated with glioma grades (Fig. 1B), and higher levels of SPRY1 patients showed a shorter survival rate than those with lower levels of SPRY1 (p. value <.0001) (Fig. 1C).